Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results

MUSTANG BIO, INC. (MBIO) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/04/2023 8-K Other Events  Interactive Data
08/16/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
08/14/2023 8-K Quarterly results
Docs: "MUSTANG BIO, INC."
07/31/2023 8-K Quarterly results
07/20/2023 8-K Quarterly results
07/11/2023 8-K Termination of a Material Definitive Agreement  Interactive Data
06/30/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
05/12/2023 8-K Quarterly results
Docs: "MUSTANG BIO, INC."
04/20/2023 8-K Quarterly results
04/03/2023 8-K Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea...
Docs: "Press Release"
03/29/2023 8-K Quarterly results
12/13/2022 8-K Quarterly results
11/25/2022 8-K Quarterly results
11/14/2022 8-K Quarterly results
08/11/2022 8-K Quarterly results
07/07/2022 8-K Quarterly results
06/24/2022 8-K Quarterly results
05/31/2022 8-K Quarterly results
05/12/2022 8-K Quarterly results
04/22/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "CONSULTING AGREEMENT"
03/23/2022 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "MUSTANG BIO, INC. Balance Sheets"
03/17/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/08/2022 8-K Quarterly results
11/12/2021 8-K Quarterly results
Docs: "MUSTANG BIO, INC. Condensed Balance Sheets September 30, December 31, 2021 2020 ASSETS Current Assets: Cash and cash equivalents $ 120,879 $ 97,804 Other receivables - related party 41 15 Prepaid expenses and other current assets 1,028 1,715 Total current assets 121,948 99,534 Property, plant and equipment, net 9,418 7,529 Fixed assets - construction in process 1,019 499 Restricted cash 1,000 1,000 Other assets 254 250 Operating lease right-of-use asset, net 1,067 1,088 Total Assets $ 134,706 $ 109,900 LIABILITIES AND STOCKHOLDERS’ EQUITY Current Liabilities: Accounts payable and accrued expenses $ 9,834 $ 8,747 Payables and accrued expenses - related party 296 490 Operating lease liabilities - short-term 329 278 Total current liabilities 10,459 9,515 Deferred income 270 — Operating lease ..."
09/28/2021 8-K Quarterly results
09/24/2021 8-K Quarterly results
08/16/2021 8-K Quarterly results
Docs: "MUSTANG BIO, INC. Condensed Balance Sheets June 30, December 31, 2021 2020 ASSETS Current Assets: Cash and cash equivalents $ 129,923 $ 97,804 Other receivables - related party 32 15 Prepaid expenses and other current assets 1,386 1,715 Total current assets 131,341 99,534 Property, plant and equipment, net 7,155 7,529 Fixed assets - construction in process 2,355 499 Restricted cash 1,000 1,000 Other assets 255 250 Operating lease right-of-use asset, net 1,101 1,088 Total Assets $ 143,207 $ 109,900 LIABILITIES AND STOCKHOLDERS’ EQUITY Current Liabilities: Accounts payable and accrued expenses $ 5,766 $ 8,747 Payables and accrued expenses - related party 249 490 Operating lease liabilities - short-term 346 278 Total current liabilities 6,361 9,515 Operating lease liabilities - long-term 1,82..."
06/22/2021 8-K Quarterly results
05/14/2021 8-K Quarterly results
03/24/2021 8-K Quarterly results
12/31/2020 8-K Quarterly results
12/04/2020 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits  ...
Docs: "CERTIFICATE OF AMENDMENT OF THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF MUSTANG BIO, INC. Mustang Bio, Inc. , a corporation organized and existing under and by virtue of the Delaware General Corporation Law , does hereby certify: 1. The Amended and Restated Certificate of Incorporation of the Corporation, as amended, is hereby amended by deleting the first sentence of Article IV, Section A thereof in its entirety and inserting the following in lieu thereof: “The total number of shares of all classes of capital stock that the Corporation shall have the authority to issue is one hundred twenty-five million shares of Common Stock, with $0.0001 par value, of which one million shares are designated as “Class A Common Stock” and the remainder are undesignated Common Stock, and two m..."
11/06/2020 8-K Quarterly results
Docs: "MUSTANG BIO, INC. Condensed Balance Sheets September 30, December 31, 2020 2019 ASSETS Current Assets: Cash and cash equivalents $ 75,251 $ 61,413 Other receivables - related party 37 19 Prepaid expenses and other current assets 344 1,631 Total current assets 75,632 63,063 Property, plant and equipment, net 7,250 6,779 Fixed assets - construction in process 821 1,157 Restricted cash 1,000 1,000 Other assets 250 250 Operating lease right-of-use asset, net 1,115 1,196 Total Assets $ 86,068 $ 73,445 LIABILITIES AND STOCKHOLDERS’ EQUITY Current Liabilities: Short-term notes payable $ — $ 1,250 Accounts payable and accrued expenses 7,054 5,668 Payables and accrued expenses - related party 305 596 Operating lease liabilities - short-term 271 257 Total current liabilities 7,630 7,771 Notes payabl..."
10/05/2020 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy